# DESCRIPTION

## FIELD OF THE INVENTION

- define invention scope

## BACKGROUND OF THE INVENTION

- introduce α4 integrin
- motivate α4 integrin antagonists
- limitations of existing antagonists
- summarize prior art

## SUMMARY OF THE INVENTION

- summarize invention

## DETAILED DESCRIPTION OF THE INVENTION

- introduce novel compounds inhibiting paxillin-α4 integrin interaction
- define technical and scientific terms
- provide nomenclature guidelines for compounds
- define alkyl, alkenyl, and alkynyl terms
- define heteroalkyl, heteroalkenyl, and heteroalkynyl terms
- define haloalkyl, haloalkenyl, and haloalkynyl terms
- define cycloalkyl and cycloalkene terms
- define heterocycle and aryl terms
- define acyl term
- describe substituents for optionally substituted structures
- define nucleic acid and related terms
- describe conservative amino acid substitutions
- define expression vector and host cells
- define gene and isolated or purified biomolecules
- describe vector and its components
- introduce embodiment 1 of the present invention
- describe ester prodrugs
- describe pharmaceutically acceptable salts
- introduce embodiment 2
- introduce embodiment 3
- introduce embodiment 4
- introduce embodiment 5
- describe pharmaceutical composition
- describe method of treating disease
- introduce embodiment 7
- introduce embodiment 8
- describe chiral centers and enantiomers
- describe polymorphs and crystal forms

### Pharmaceutical Formulation and Administration:

- formulate active ingredients in pharmaceutically acceptable formulations
- prepare injectable liquid solutions or suspensions
- describe container and label requirements
- administer therapeutically effective amount of active ingredient
- prepare pharmaceutically acceptable salts
- determine toxicity and therapeutic efficacy
- estimate therapeutically effective dose from cell culture assays
- formulate and administer pharmaceutical compositions

## EXAMPLES

### Experimental Procedures

- describe cell lines
- describe reagents
- generate recombinant proteins
- perform ELISA assay
- analyze inhibition of α4 leupaxin interaction
- perform high throughput screening
- perform coimmunoprecipitation and Western blotting
- perform migration assay
- perform spreading assay and cytotoxicity assay

### Example 1

- describe high-throughput screening

### Example 2

- describe compound 6-B345TTQ inhibiting α4-integrin interaction
- analyze specificity of compound 6-B345TTQ
- determine nature of inhibition by 6-345TTQ

### Example 3

- describe effect of compound 6-B345TTQ on α4-mediated migration
- analyze specificity of compound 6-B345TTQ on cell migration
- describe effect of compound 6-B345TTQ on cell spreading

### Example 4

- describe effect of compound 6-B345TTQ on leukocyte recruitment in vivo

### Example 5

- describe importance of integrin α4β1 signaling in LECs

## Equivalents

- disclaim limitations
- describe scope of invention

